Aurelien Haustrate
Villeneuve-d'ascq, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Targeting TRPV6/CXCR4 complexes prevents castration-resistant prostate cancer metastasis to the bone.
Journal: Signal transduction and targeted therapy
Published: April 08, 2025
Trpv6 channel targeting using monoclonal antibody induces prostate cancer cell apoptosis and tumor regression.
Journal: Cell death & disease
Published: November 20, 2023
Characterization of the TRPV6 calcium channel-specific phenotype by RNA-seq in castration-resistant human prostate cancer cells.
Journal: Frontiers in genetics
Published: May 02, 2023
Insights into the regulation of cellular Mn2+ homeostasis via TMEM165.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: December 08, 2022
A Novel Anti-TRPV6 Antibody and Its Application in Cancer Diagnosis In Vitro.
Journal: International journal of molecular sciences
Published: October 26, 2022
NALCN-mediated sodium influx confers metastatic prostate cancer cell invasiveness.
Journal: The EMBO journal
Published: July 23, 2022
Retraction notice to "TRPV6 calcium channel regulation, downstream pathways, and therapeutic targeting in cancer" [Cell Calcium (2019) 117-124].
Journal: Cell calcium
Published: January 11, 2020
Role of the TRPV Channels in the Endoplasmic Reticulum Calcium Homeostasis.
Journal: Cells
Published: October 14, 2019
Monoclonal Antibodies Targeting Ion Channels and Their Therapeutic Potential.
Journal: Frontiers in pharmacology
Published: November 08, 2018
Last Updated: 09/26/2026